Dec. 28, 2022

EG-011: WASp as a New Target for Heme Cancers

EG-011

WASp activator in vivo antitumor activity fortuitous scaffold hopping from ibrutinib bioRxiv, 25 November 2022 Institute of Oncology Research, Bellinzona, CH

twitterlinkedinprintemail